Catalyst Wire Dossier Catalyst Wire Dossier

Interferon alpha (low-dose)

Interferon alpha · Nobel Pharmaceuticals
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Interferon alpha (low-dose), covering 2009-06-16 to 2022-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms [Phase 3]

See pricing